Panacea Index Logo

Command Palette

Search for a command to run...

Genetic variation of fasting glucose and changes in glycemia in response to 2-year weight-loss diet intervention: the POUNDS LOST trial.

International journal of obesity (2005)
July 1, 2016
T Wang et al. (7 authors)
Comparative StudyJournal ArticleRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether genetic variation modifies the effect of weight-loss diets, particularly high-fat diets, on changes in glycemic traits.

Results Summary

The study found that participants with higher genetic risk scores showed increased fasting glucose on a high-fat diet, while those with lower scores showed decreased fasting glucose; no significant genetic association was observed in the low-fat diet group.

Population

733 adults participating in a weight-loss trial.

Effective Dosage

Not specified

Duration

2 years

Interactions

None mentioned

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
weight-loss diets
neutral
fasting glucose
733 adults from the POUNDS LOST trial
-
interaction between the GRS and dietary fat on 6-month changes
#1
weight-loss diets
neutral
homeostasis model assessment of insulin resistance (HOMA-IR)
733 adults from the POUNDS LOST trial
-
interaction between the GRS and dietary fat on 6-month changes
#2
weight-loss diets
neutral
insulin sensitivity (HOMA-S)
733 adults from the POUNDS LOST trial
-
interaction between the GRS and dietary fat on 6-month changes
#3
high-fat diet
increase
fasting glucose
participants in the highest GRS tertile
-
participants in the highest GRS tertile showed increased
#4
high-fat diet
decrease
fasting glucose
participants in the lowest GRS tertile
-
participants in the lowest tertile showed decreased
#5
low-fat diet
no change
fasting glucose
participants in the low-fat diet group
-
the genetic association was not significant
#6
low-fat diet
increase
glucose metabolism
participants with a higher genetic risk
-
benefit more by eating
#7
Abstract

OBJECTIVE: Weight-loss intervention through diet modification has been widely used to improve obesity-related hyperglycemia; however, little is known about whether genetic variation modifies the intervention effect. We examined the interaction between weight-loss diets and genetic variation of fasting glucose on changes in glycemic traits in a dietary intervention trial. RESEARCH DESIGN AND METHODS: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial is a randomized, controlled 2-year weight-loss trial. We assessed overall genetic variation of fasting glucose by calculating a genetic risk score (GRS) based on 14 fasting glucose-associated single nucleotide polymorphisms, and examined the progression in fasting glucose and insulin levels, and insulin resistance and insulin sensitivity in 733 adults from this trial. RESULTS: The GRS was associated with 6-month changes in fasting glucose (P<0.001), fasting insulin (P=0.042), homeostasis model assessment of insulin resistance (HOMA-IR, P=0.009) and insulin sensitivity (HOMA-S, P=0.043). We observed significant interaction between the GRS and dietary fat on 6-month changes in fasting glucose, HOMA-IR and HOMA-S after multivariable adjustment (P-interaction=0.007, 0.045 and 0.028, respectively). After further adjustment for weight loss, the interaction remained significant on change in fasting glucose (P=0.015). In the high-fat diet group, participants in the highest GRS tertile showed increased fasting glucose, whereas participants in the lowest tertile showed decreased fasting glucose (P-trend <0.001); in contrast, the genetic association was not significant in the low-fat diet group (P-trend=0.087). CONCLUSIONS: Our data suggest that participants with a higher genetic risk may benefit more by eating a low-fat diet to improve glucose metabolism.

Medical Subject Headings (MeSH)
AdultAgedBlood GlucoseDiet, ReducingFastingFemaleGenetic VariationGlycated HemoglobinGlycemic IndexHumansInsulinInsulin ResistanceMaleMiddle AgedObesityPolymorphism, Single NucleotideTreatment OutcomeUnited StatesWeight Loss
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations20
Citations/Year2.2
Relative Citation Ratio0.78
NIH Percentile41.2%
Research Impact Scores
APT Score0.75
Weight Score1.93
Normalized Score0.67
Related Supplements